| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 21, 2021 |
| Accession Number: | 0001193125-21-119305 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 21, 2021 |
| Accession Number: | 0001193125-21-119305 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Save time and jump to the most important pieces.
SC 13G/A - FIVE PRIME THERAPEUTICS, INC. (0001175505) (Subject)
15-12B - FIVE PRIME THERAPEUTICS, INC. (0001175505) (Filer)
EFFECT - FIVE PRIME THERAPEUTICS, INC. (0001175505) (Filer)